A detailed history of Woodline Partners LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Woodline Partners LP holds 948,702 shares of RGLS stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
948,702
Previous 947,685 0.11%
Holding current value
$1.61 Million
Previous $1.7 Million 12.21%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.46 - $1.9 $1,484 - $1,932
1,017 Added 0.11%
948,702 $1.49 Million
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.8 $1.7 Million - $2.65 Million
947,685 New
947,685 $1.7 Million

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $24.9M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.